Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Salacia oblonga
An Ayurvedic anti-diabetic herb; salacinol and kotalanol are specific alpha-glucosidase inhibitors shown to be as effective as pharmaceutical acarbose for post-meal blood glucose.
Salacia oblonga is an Ayurvedic herb primarily used for diabetes management, with its key active compounds salacinol and kotalanol acting as potent alpha-glucosidase inhibitors to reduce postprandial blood glucose spikes. It also contains mangiferin and lupeol, which contribute to insulin sensitization and anti-inflammatory effects, supporting its traditional use in obesity and metabolic disorders.
Salacinol and kotalanol competitively inhibit intestinal alpha-glucosidase enzymes (maltase, sucrase, glucoamylase), delaying carbohydrate digestion and absorption, thereby lowering postprandial hyperglycemia. Mangiferin activates AMPK and enhances insulin sensitivity, while lupeol modulates PPARγ to reduce adipogenesis and inflammation. These combined actions improve glycemic control and support weight management.
An Ayurvedic anti-diabetic herb; salacinol and kotalanol are specific alpha-glucosidase inhibitors shown to be as effective as pharmaceutical acarbose for post-meal blood glucose.
Salacia oblonga is an Ayurvedic herb primarily used for diabetes management, with its key active compounds salacinol and kotalanol acting as potent alpha-glucosidase inhibitors to reduce postprandial blood glucose spikes. It also contains mangiferin and lupeol, which contribute to insulin sensitization and anti-inflammatory effects, supporting its traditional use in obesity and metabolic disorders.
Salacinol and kotalanol competitively inhibit intestinal alpha-glucosidase enzymes (maltase, sucrase, glucoamylase), delaying carbohydrate digestion and absorption, thereby lowering postprandial hyperglycemia. Mangiferin activates AMPK and enhances insulin sensitivity, while lupeol modulates PPARγ to reduce adipogenesis and inflammation. These combined actions improve glycemic control and support weight management.